Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuya Arai

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Gels (Basel, Switzerland)|October 26, 2022
Wet Grinder-Treated Okara Improved Both Mechanical Properties and Intermolecular Forces of Soybean Protein Isolate GelsYuya Arai, Katsuyoshi Nishinari, Takao Nagano
International Journal of Molecular Sciences|November 9, 2024
Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib ActivitySeiichi Okabe, Yuya Arai, Akihiko Gotoh
Foods (Basel, Switzerland)|February 10, 2021
Developing Soybean Protein Gel-Based Foods from Okara Using the Wet-Type Grinder MethodYuya Arai, Katsuyoshi Nishinari, Takao Nagano
Discover Oncology|December 24, 2024
Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemiaSeiichi Okabe, Yuya Arai, Akihiko Gotoh
Cancer Biomarkers : Section a of Disease Markers|August 30, 2024
Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cellsSeiichi Okabe, Mitsuru Moriyama, Yuya Arai, et al.
Cancer Reports (Hoboken, N.J.)|June 20, 2025
Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia-Induced Vulnerabilities in Multiple MyelomaSeiichi Okabe, Yuya Arai, Yuko Tanaka, et al.
Cancer Innovation|September 2, 2025
Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid LeukemiaSeiichi Okabe, Yuya Arai, Akihiko Gotoh, et al.
SLAS Technology|March 30, 2023
SAGAS: Simulated annealing and greedy algorithm scheduler for laboratory automationYuya Arai, Ko Takahashi, Takaaki Horinouchi, et al.
Journal of Cellular and Molecular Medicine|February 16, 2026
Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell LinesSeiichi Okabe, Seiichiro Yoshizawa, Yuya Arai, et al.
Anticancer Research|February 27, 2026
Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia CellsSeiichi Okabe, Seiichiro Yoshizawa, Kai Osone, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Gels (Basel, Switzerland)|October 26, 2022
Wet Grinder-Treated Okara Improved Both Mechanical Properties and Intermolecular Forces of Soybean Protein Isolate GelsYuya Arai, Katsuyoshi Nishinari, Takao Nagano
International Journal of Molecular Sciences|November 9, 2024
Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib ActivitySeiichi Okabe, Yuya Arai, Akihiko Gotoh
Foods (Basel, Switzerland)|February 10, 2021
Developing Soybean Protein Gel-Based Foods from Okara Using the Wet-Type Grinder MethodYuya Arai, Katsuyoshi Nishinari, Takao Nagano
Discover Oncology|December 24, 2024
Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemiaSeiichi Okabe, Yuya Arai, Akihiko Gotoh
Cancer Biomarkers : Section a of Disease Markers|August 30, 2024
Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cellsSeiichi Okabe, Mitsuru Moriyama, Yuya Arai, et al.
Cancer Reports (Hoboken, N.J.)|June 20, 2025
Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia-Induced Vulnerabilities in Multiple MyelomaSeiichi Okabe, Yuya Arai, Yuko Tanaka, et al.
Cancer Innovation|September 2, 2025
Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid LeukemiaSeiichi Okabe, Yuya Arai, Akihiko Gotoh, et al.
SLAS Technology|March 30, 2023
SAGAS: Simulated annealing and greedy algorithm scheduler for laboratory automationYuya Arai, Ko Takahashi, Takaaki Horinouchi, et al.
Journal of Cellular and Molecular Medicine|February 16, 2026
Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell LinesSeiichi Okabe, Seiichiro Yoshizawa, Yuya Arai, et al.
Anticancer Research|February 27, 2026
Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia CellsSeiichi Okabe, Seiichiro Yoshizawa, Kai Osone, et al.
Pageof 2